March 3, 2021, Wednesday

From BIMIB

Jump to: navigation, search

Difference between revisions of "Accelerator Single Cells Cancer Evolution in the Clinic"

 
Line 1: Line 1:
 
The BIMIB group (bimib.disco.unimib.it) has become involved in a multidisciplinary project involving five different Institutions in Italy and UK. This ambitious project, entitled “Single-cell cancer evolution in the clinic”, aims at studying the evolutionary trajectories of cell clones in cancer tissues and in patient-derived organoids, in order to define effective and data-driven personalized therapeutic strategies, and it is funded by a joint Cancer Research UK (CRUK), Asociación Española Contra el Cáncer (FA-AECC) and Associazione Italiana per la Ricerca sul Cancro (AIRC) Accelerator Award.
 
The BIMIB group (bimib.disco.unimib.it) has become involved in a multidisciplinary project involving five different Institutions in Italy and UK. This ambitious project, entitled “Single-cell cancer evolution in the clinic”, aims at studying the evolutionary trajectories of cell clones in cancer tissues and in patient-derived organoids, in order to define effective and data-driven personalized therapeutic strategies, and it is funded by a joint Cancer Research UK (CRUK), Asociación Española Contra el Cáncer (FA-AECC) and Associazione Italiana per la Ricerca sul Cancro (AIRC) Accelerator Award.
 +
 +
 +
<!--
  
 
== '''We are hiring''' ==
 
== '''We are hiring''' ==
  
<!--
+
 
  
 
=== Post Doc ===
 
=== Post Doc ===

Latest revision as of 19:40, 10 December 2020

The BIMIB group (bimib.disco.unimib.it) has become involved in a multidisciplinary project involving five different Institutions in Italy and UK. This ambitious project, entitled “Single-cell cancer evolution in the clinic”, aims at studying the evolutionary trajectories of cell clones in cancer tissues and in patient-derived organoids, in order to define effective and data-driven personalized therapeutic strategies, and it is funded by a joint Cancer Research UK (CRUK), Asociación Española Contra el Cáncer (FA-AECC) and Associazione Italiana per la Ricerca sul Cancro (AIRC) Accelerator Award.